VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $318,000 | +45.9% | 13,700 | 0.0% | 0.00% | +50.0% |
Q1 2018 | $218,000 | -59.3% | 13,700 | -71.7% | 0.00% | -60.0% |
Q1 2017 | $535,000 | -9.0% | 48,470 | +19.8% | 0.01% | 0.0% |
Q4 2016 | $588,000 | -40.8% | 40,470 | -0.0% | 0.01% | -37.5% |
Q3 2016 | $994,000 | -42.5% | 40,489 | -52.8% | 0.01% | -46.7% |
Q2 2016 | $1,728,000 | -20.3% | 85,789 | +4.0% | 0.02% | -28.6% |
Q1 2016 | $2,169,000 | -62.5% | 82,473 | +44.8% | 0.02% | -62.5% |
Q4 2015 | $5,791,000 | -34.8% | 56,973 | +14.4% | 0.06% | -39.8% |
Q3 2015 | $8,880,000 | -22.2% | 49,784 | -3.1% | 0.09% | -34.0% |
Q2 2015 | $11,415,000 | -25.7% | 51,384 | -16.3% | 0.14% | -19.0% |
Q1 2015 | $15,356,000 | +32.7% | 61,374 | -11.8% | 0.17% | +30.8% |
Q4 2014 | $11,574,000 | +111.7% | 69,584 | +67.0% | 0.13% | -9.5% |
Q3 2014 | $5,468,000 | -4.7% | 41,676 | -8.4% | 0.15% | -4.5% |
Q2 2014 | $5,735,000 | +15.0% | 45,476 | +32.7% | 0.15% | +2.7% |
Q1 2014 | $4,985,000 | +7.0% | 34,276 | -8.3% | 0.15% | -15.3% |
Q4 2013 | $4,658,000 | +36.1% | 37,376 | +17.3% | 0.18% | +19.6% |
Q3 2013 | $3,422,000 | -48.0% | 31,876 | -57.9% | 0.15% | -35.9% |
Q2 2013 | $6,584,000 | – | 75,700 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |